Science review: Redox and oxygen-sensitive transcription factors in the regulation of oxidant-mediated lung injury: Role for hypoxia-inducible factor-1α

Critical Care

Volumn 7, Issue 1, 2003, Pages 47-54

  Haddad, John J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Antioxidant; Hypoxia inducible factor ; Injury; Lung; Oxygen; Redox; Transcription factors

Indexed keywords

GELATINASE B; HYPOXIA INDUCIBLE FACTOR 1ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; INTERLEUKIN 8; OXIDIZING AGENT; OXYGEN; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ARTIFICIAL VENTILATION; BURKHOLDERIA CEPACIA; CYSTIC FIBROSIS; CYTOKINE PRODUCTION; DISEASE COURSE; GENE EXPRESSION; GENETIC REGULATION; HOMEOSTASIS; HOST RESISTANCE; HUMAN; HYPOXEMIA; INFECTION SENSITIVITY; INFLAMMATION; LUNG ALVEOLUS MACROPHAGE; LUNG INFECTION; LUNG INJURY; LUNG TRANSPLANTATION; MOUSE; NONHUMAN; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN SECRETION; REPERFUSION; REVIEW; SENSITIVITY ANALYSIS; SIGNAL TRANSDUCTION; STIMULUS RESPONSE; TRANSCRIPTION REGULATION;

ANIMALS; ANOXEMIA; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOCOMPROMISED HOST; INFLAMMATION; LUNG TRANSPLANTATION; MICE; NUCLEAR PROTEINS; OXIDATION-REDUCTION; OXIDATIVE STRESS; RESPIRATION, ARTIFICIAL; RESPIRATORY DISTRESS SYNDROME, ADULT; TRANSCRIPTION FACTORS;

EID: 0037318947     PISSN: 13648535     EISSN: None     Source Type: Journal    
DOI: 10.1186/cc1840     Document Type: Review

References (75)

1. D'Angio CT, Finkelstein JN: Oxygen regulation of gene expression: a study in opposites. Mol Genet Metab 2000, 71:371-380.
2. Alder V, Yin Z, Tew KD, Ronai Z: Role of redox potential and reactive oxygen species in stress signaling. Oncogene 1999, 18:6104-6111.
3. Crapo JD, Harmsen AG, Sherman MP, Musson RA: Pulmonary immunobiology and inflammation in pulmonary diseases. Am J Respir Crit Care Med 2000, 162:1983-1986.
4. Haddad JJ, Olver RE, Land SC: Antioxidant/pro-oxidant equilibrium regulates HIF-1α and NF-κB redox sensitivity: evidence for inhibition by glutathione oxidation in alveolar epithelial cells. J Biol Chem 2000, 275:21130-21139.
5. Pugin J, Dunn I, Jolliet P, Tassaux D, Magnenat JL, Nicod LP, Chevrolet JC: Activation of human macrophages by mechanical ventilation in vitro. Am J Physiol 1998, 275:L1040-L1050.
6. Leeper-Woodford SK, Detmer K: Acute hypoxia increases alveolar macrophage tumor necrosis factor activity and alters NF-κB expression. Am J Physiol 1999, 276:L909-L916.
7. Lentsch AB, Yoshidome H, Warner RL, Ward PA, Edwards MJ: Secretory leukocyte protease inhibitor in mice regulates local and remote organ inflammatory injury induced by hepatic ischemia/reperfusion. Gastroenterology 1999, 117:953-961.
8. Chapman WC, Debelak JP, Wright Pinson C, Washington MK, Atkinson JB, Venkatakrishnan A, Blackwell TS, Christman JW: Hepatic cryo-ablation, but not radio-frequency ablation, results in lung inflammation. Ann Surg 2000, 231:752-761.
9. Chapman WC, Debelak JP, Blackwell TS, Gainer KA, Christman JW, Pinson CW, Brigham KL, Parker RE: Hepatic cryo-ablation-induced acute lung injury: pulmonary hemodynamic and permeability effects in a sheep model. Arch Surg 2000, 135:667-672.
10. Basbaum C, Lemjabbar H, Longphre M, Li D, Gensch E, McNamara N: Control of mucin transcription by diverse injury-induced signaling pathways. Am J Respir Crit Care Med 1999, 160:S44-S48.
11. Yoshidome H, Kato A, Edwards MJ, Lentsch AB: Interleukin-10 inhibits pulmonary NF-κB activation and lung injury induced by hepatic ischemia-reperfusion. Am J Physiol 1999, 277:-L919-L923.
12. Armstead VE, Opentanova IL, Minchenko AG, Lefer AM: Tissue factor expression in vital organs during murine traumatic shock: role of transcription factors AP-1 and NF-κB. Anesthesiology 1999, 91:1844-1852.
13. Washington K, Debelak JP, Gobbell C, Sztipanovits DR, Shyr Y, Olson S, Chapman WC: Hepatic cryo-ablation-induced acute lung injury: histopathologic findings. J Surg Res 2001, 95:1-7.
14. Ross SD, Kron IL, Gangemi JJ, Shockey KS, Stoler M, Kern JA, Tribble CG, Laubach VE: Attenuation of lung reperfusion injury after transplantation using an inhibitor of nuclear factor-κB. Am J Physiol Lung Cell Mol Physiol 2000, 279:L528-L536.
15. -/- mice. Infect Immun 2001, 69:5138-5150.
16. Lentsch AB, Ward PA: Regulation of experimental lung inflammation. Respir Physiol 2001, 128:17-22.
17. Fan J, Ye RD, Malik AB: Transcriptional mechanisms of acute lung injury. Am J Physiol Lung Cell Mol Physiol 2001, 281:-L1037-L1050.
18. Kupfner JG, Arcaroli JJ, Yum HK, Nadler SG, Yang KY, Abraham E: Role of NF-κB in endotoxemia-induced alterations of lung neutrophil apoptosis. J Immunol 2001, 167:7044-7051.
19. Park GY, Le S, Park KH, Le CT, Kim YW, Han SK, Shim YS, Yoo CG: Anti-inflammatory effect of adenovirus-mediated IκB-α overexpression in respiratory epithelial cells. Eur Respir J 2001, 18:801-809.
20. Semenza GL: Oxygen-regulated transcription factors and their role in pulmonary disease. Respir Res 2000, 11:159-162.
21. Cuzzocrea S, Chatterjee PK, Mazzon E, Dugo L, Serraino I, Britti D, Mazzullo G, Caputi AP, Thiemermann C: Pyrrolidine dithiocarbamate attenuates the development of acute and chronic inflammation. Br J Pharmacol 2002, 135:496-510.
22. Sunil VR, Connor AJ, Guo Y, Laskin JD, Laskin DL: Activation of type II alveolar epithelial cells during acute endotoxemia. Am J Physiol Lung Cell Mol Physiol 2002, 282:L872-L880.
23. 2/ROS)-dependent release of IL-1β, IL-6 and TNF-α: evidence of cytokines as oxygen-sensitive mediators in the alveolar epithelium. Cytokine 2001, 13:-138-147.
24. Haddad JJ, Choudhary KK, Land SC: The ex vivo differential expression of apoptosis signaling cofactors in the developing perinatal lung: essential role of oxygenation during the transition from placental to pulmonary-based respiration. Biochem Biophys Res Commun 2001, 281:311-316.
25. Haddad JJ, Safieh-Garabedian B, Saadé NE, Land SC: Thiol regulation of pro-inflammatory cytokines reveals a novel immunopharmacological potential of glutathione in the alveolar epithelium. J Pharmacol Exp Ther 2001, 296:996-1005.
26. + conductance in fetal alveolar cells. Biochem Biophys Res Commun 2001, 281:-987-992.
27. + transport in rat fetal distal lung epithelial cells. J Physiol 2001, 532:105-113.
28. Haddad JJ, Safieh-Garabedian B, Saadé NE, Land SC: The biphasic immunoregulation of pyrimidylpiperazine (Y-40138) is IL-10 sensitive and requires NF-κB targeting in the alveolar epithelium. Br J Pharmacol 2001, 133:49-60.
29. Haddad JJ, Land SC: Nuclear factor-κB blockade attenuates but does not abrogate lipopolysaccharide-dependent tumor necrosis factor-α biosynthesis in alveolar epithelial cells. Biochem Biophys Res Commun 2001, 285:267-272.
30. Haddad JJ: Glutathione depletion is associated with augmenting a proinflammatory signal: evidence for an antioxidant/pro-oxidant mechanism regulating cytokines in the alveolar epithelium. Cytokines Cell Mol Ther 2000, 6:177-187.
31. Haddad JJ, Land SC: Amiloride blockades lipopolysaccharide-induced proinflammatory cytokine biosynthesis in an IκB-α/NF-κB-dependent mechanism. Evidence for the amplification of an antiinflammatory pathway in the alveolar epithelium. Am J Respir Cell Mol Biol 2002, 26:114-126.
32. Haddad JJ: L-Buthionine-(S,R)-sulfoximine, an irreversible inhibitor of γ-glutamylcysteine synthetase, augments LPS-mediated pro-inflammatory cytokine biosynthesis: evidence for the implication of an IκB-α/NF-κB insensitive pathway. Eur Cytokine Netw 2001, 12:614-624.
33. Haddad JJ, Saadé NE, Safieh-Garabedian B: Redox regulation of TNF-α biosynthesis: augmentation by irreversible inhibition of gamma-glutamylcysteine synthetase and the involvement of an IκB-α/NF-κB-independent pathway in alveolar epithelial cells. Cell Signal 2002, 14:211-218.
34. Haddad JJ, Land SC: Redox/ROS regulation of lipopolysaccharide-induced mitogen-activated protein kinase (MAPK) activation and MAPK-mediated TNF-α biosynthesis. Br J Pharmacol 2002, 135:520-536.
35. p38-dependent regulation of pro-inflammatory cytokine production. Biochem Pharmacol 2002, 63:305-320.
36. Haddad JJ, Fahlman CS: Nuclear factor-κB-independent regulation of lipopolysaccharide-mediated interleukin-6 biosynthesis. Biochem Biophys Res Commun 2002, 291:1045-1051.
37. Rahman I, Mulier B, Gilmour PS, Watchorn T, Donaldson K, Jeffery PK, MacNee W: Oxidant-mediated lung epithelial cell tolerance: the role of intracellular glutathione and nuclear factor-κB. Biochem Pharmacol 2001, 62:787-794.
38. MacNee W, Rahman I: Is oxidative stress central to the pathogenesis of chronic obstructive pulmonary disease? Trends Mol Med 2001, 7:55-62.
39. Rahman I, MacNee W: Regulation of redox glutathione levels and gene transcription in lung inflammation: therapeutic approaches. Free Radic Biol Med 2000, 28:1405-1420.
40. Rahman I, van Schadewijk AA, Hiemstra PS, Stolk J, van Krieken JH, MacNee W, de Boer WI: Localization of γ-glutamylcysteine synthetase mRNA expression in lungs of smokers and patients with chronic obstructive pulmonary disease. Free Radic Biol Med 2000, 28:920-925.
41. Haddad JJ: Oxygen-sensitive pro-inflammatory cytokines, apoptosis signaling and redox-responsive transcription factors in development and pathophysiology. Cytokines Cell Mol Ther 2001, 7:1-14.
42. Haddad JJ: Oxygen homeostasis, thiol equilibrium and redox regulation of signaling transcription factors in the alveolar epithelium. Cell Signal 2002, 14:799-810.
43. Semenza GL: HIF-1 and mechanisms of hypoxia sensing. Curr Opin Cell Biol 2001, 13:167-171.
44. Semenza GL: HIF-1 and human disease: one highly involved factor. Genes Dev 2000, 14:1983-1991.
45. Semenza GL: Involvement of hypoxia-inducible factor 1 in human cancer. Intern Med 2002, 41:79-83.
46. Semenza GL: HIF-1 and tumor progression: pathophysiology and therapeutics. Trends Mol Med 2002, 8:S62-S67.
47. Hellwig-Bürgel T, Rutkowski K, Metzen E, Fandrey J, Jelkmann W: Interleukin-1β and tumor necrosis factor-alpha stimulate DNA binding of hypoxia-inducible factor-1. Blood 1999, 94:1561-1567.
48. El Awad B, Kreft B, Wolber EM, Hellwig-Bürgel T, Metzen E, Fandrey J, Jelkmann W: Hypoxia and interleukin-1β stimulate vascular endothelial growth factor production in human proximal tubular cells. Kidney Int 2000, 58:43-50.
49. Stiehl DP, Jelkmann W, Wenger RH, Hellwig-Bürgel T: Normoxic induction of the hypoxia-inducible factor 1α by insulin and interleukin-1β involves the phosphatidylinositol 3-kinase pathway. FEBS Lett 2002, 512:157-162.
50. Haddad JJ, Land SC: A non-hypoxic, ROS-sensitive pathway mediates TNF-α-dependent regulation of HIF-1α. FEBS Lett 2001, 505:269-274.
51. Haddad JJ: Recombinant human interleukin (IL)-1β-mediated regulation of hypoxia-inducible factor-1α (HIF-1α) stabilization, nuclear translocation and activation requires an antioxidant/reactive oxygen species (ROS)-sensitive mechanism. Eur Cytokine Netw 2002, 13:250-260.
52. Becker PM, Alcasabas A, Yu AY, Semenza GL, Bunton TE: Oxygen-independent upregulation of vascular endothelial growth factor and vascular barrier dysfunction during ventilated pulmonary ischemia in isolated ferret lungs. Am J Respir Cell Mol Biol 2000, 22:272-279.
53. Hierholzer C, Harbrecht BG, Billiar TR, Tweardy DJ: Hypoxia-inducible factor-1 activation and cyclooxygenase-2 induction are early reperfusion-independent inflammatory events in hemorrhagic shock. Arch Orthop Trauma Surg 2001, 121:219-222.
54. Shoshani T, Faerman A, Mett I, Zelin E, Tenne T, Gorodin S, Moshel Y, Elbaz S, Budanov A, Chajut A, Kalinski H, Kamer I, Rozen A, Mor O, Keshet E, Leshkowitz D, Einat P, Skaliter R, Feinstein E: Identification of a novel hypoxia-inducible factor 1-responsive gene, RTP801, involved in apoptosis. Mol Cell Biol 2002, 22:2283-2293.
55. Shimaoka M, Fujino Y, Taenaka N, Hiroi T, Kiyono H, Yoshiya II. High frequency oscillatory ventilation attenuates the activation of alveolar macrophages and neutrophils in lung injury. Crit Care 1998, 2:35-39.
56. Pinsky MR: Toward a better ventilation strategy for patients with acute lung injury. Crit Care 2000, 4:205-206.
57. Wesselkamper SC, Prows DR, Biswas P, Willeke K, Bingham E, Leikauf GD: Genetic susceptibility to irritant-induced acute lung injury in mice. Am J Physiol Lung Cell Mol Physiol 2000, 279:L575-L582.
58. Leikauf GD, McDowell SA, Bachurski CJ, Aronow BJ, Gammon K, Wesselkamper SC, Hardie W, Wiest JS, Leikauf JE, Korfhagen TR, Prows DR: Functional genomics of oxidant-induced lung injury. Adv Exp Med Biol 2001, 500:479-487.
59. Leikauf GD, McDowell SA, Wesselkamper SC, Hardie WD, Leikauf JE, Korfhagen TR, Prows DR: Acute lung injury: functional genomics and genetic susceptibility. Chest 2002, 121:-70S-75S.
60. Pittet JF, MacKersie RC, Martin TR, Matthay MA: Biological markers of acute lung injury: Prognostic and pathogenetic significance. Am J Respir Crit Care Med 1997, 155:1187-1205.
61. Kaminski N, Allard JD, Pittet JF, Zuo F, Griffiths MJ, Morris D, Huang X, Sheppard D, Heller RA: Global analysis of gene expression in pulmonary fibrosis reveals distinct programs regulating lung inflammation and fibrosis. Proc Natl Acad Sci USA 2000, 97:1778-1783.
62. Miyazaki H, Broaddus VC, Wiener-Kronish JP, Sawa T, Pittet JF, Kravchenko V, Mathison JC, Nishizawa H, Hattori S, Yamakawa T, Yamada H, Kudoh I: The effects of two antiinflammatory pre-treatments on bacterial-induced lung injury. Anesthesiology 1999, 90:1650-1662.
63. Grimaldo DA, Wiener-Kronish JP, Jurson T, Shaughnessy TE, Curtis JR, Liu LL: A randomized, controlled trial of advanced care planning discussions during preoperative evaluations. Anesthesiology 2001, 95:43-50.
64. Ernst EJ, Hashimoto S, Guglielmo J, Sawa T, Pittet JF, Kropp H, Jackson JJ, Wiener-Kronish JP: Effects of antibiotic therapy on Pseudomonas aeruginosa-induced lung injury in a rat model. Antimicrob Agents Chemother 1999, 43:2389-2394.
65. Davis K Jr, Johannigman JA, Campbell RS, Marraccini A, Luchette FA, Frame SB, Branson RD: The acute effects of body position strategies and respiratory therapy in paralyzed patients with acute lung injury. Crit Care 2001, 5:81-87.
66. Kheradmand F, Wiener-Kronish JP, Corry DB: Assessment of operative risk for patients with advanced lung disease. Clin Chest Med 1997, 18:483-494.
67. Song C, Al-Mehdi AB, Fisher AB: An immediate endothelial cell signaling response to lung ischemia. Am J Physiol Lung Cell Mol Physiol 2001, 281:L993-L1000.
68. Merker MP, Pitt BR, Choi AM, Hassoun PM, Dawson CA, Fisher AB: Lung redox homeostasis: emerging concepts. Am J Physiol Lung Cell Mol Physiol 2000, 279:L413-L417.
69. 2-isoprostanes in plasma of smokers. Cancer Epidemiol Biomarkers Prev 2002, 11:7-13.
70. van Der Vliet A, Eiserich JP, Cross CE: Nitric oxide: a pro-inflammatory mediator in lung disease? Respir Res 2000, 1:67-72.
71. Cross CE, van der Vliet A, Eiserich JP: Peroxidases wheezing their way into asthma. Am J Respir Crit Care Med 2001, 164:-1102-1103.
72. Casaburi R, Mahler DA, Jones PW, Wanner A, San PG, ZuWallack RL, Menjoge SS, Serby CW, Witek T Jr: A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease. Eur Respir J 2002, 19:217-224.
73. Burrows B, Bloom JW, Traver GA, Cline MG: The course and prognosis of different forms of chronic airways obstruction in a sample from the general population. N Engl J Med 1987, 317:1309-1314.
74. Kaplan LJ, Bailey H, Formosa V: Airway pressure release ventilation increases cardiac performance in patients with acute lung injury/adult respiratory distress syndrome. Crit Care 2001, 5:221-226.
75. dos Santos CC, Zhang H, Slutsky AS: From bench to bedside: bacterial growth and cytokines. Crit Care 2002, 6:4-6.